Clinical Trials for Aptose Biosciences

Explore 1 clinical trials worldwide

Showing 1-1 of 1 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Aptose Biosciences

Clinical Trials (1)

NCT03850574
Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia
PHASE1/PHASE2Recruiting
240 participants
Started: Mar 11, 2019 · Completed: Apr 30, 2027
5 conditions1 sponsor34 locations